Written questions by Snowden.

Whether his Department has commissioned research on the incidence of postural tachycardia syndrome in patients with long covid.

We are investing in additional capacity to deliver appointments to help bring waiting lists and times down. The Elective Reform Plan, published in January 2025, sets out the specific productivity and reform efforts needed to return to the constitutional standard, that 92% of patients to wait no longer than 18 weeks from referral to treatment by March 2029.Additionally, the shifts outlined in our 10-Year Health Plan will free up hospital-based consultants’ time by shifting care from hospitals to communities, utilising digital technology to reduce administrative burdens, and promoting prevention to reduce the onset and severity of conditions that lead to hospital admissions. This includes expanding community-based services, employing artificial intelligence for productivity, developing integrated neighbourhood health teams, and investing in digital tools and data. These shifts will allow specialists to focus on more complex cases of postural tachycardia syndrome (PoTS), enabling earlier identification and management, and improved patient outcomes.The Department funds health and care research through the National Institute for Health and Care Research (NIHR). The NIHR has supported a broad portfolio of research into long COVID, including understanding the links between long COVID and PoTS. The £3.35 million LOng COvid Multidisciplinary consortium: Optimising Treatments and servIces acrOss the NHS, or LOCOMOTION, study confirmed that people with long COVID are more likely than others to have orthostatic intolerance, and that these problems are relatively common.

What steps his Department is taking to improve early diagnosis rates for postural tachycardia syndrome.

We are investing in additional capacity to deliver appointments to help bring waiting lists and times down. The Elective Reform Plan, published in January 2025, sets out the specific productivity and reform efforts needed to return to the constitutional standard, that 92% of patients to wait no longer than 18 weeks from referral to treatment by March 2029.Additionally, the shifts outlined in our 10-Year Health Plan will free up hospital-based consultants’ time by shifting care from hospitals to communities, utilising digital technology to reduce administrative burdens, and promoting prevention to reduce the onset and severity of conditions that lead to hospital admissions. This includes expanding community-based services, employing artificial intelligence for productivity, developing integrated neighbourhood health teams, and investing in digital tools and data. These shifts will allow specialists to focus on more complex cases of postural tachycardia syndrome (PoTS), enabling earlier identification and management, and improved patient outcomes.The Department funds health and care research through the National Institute for Health and Care Research (NIHR). The NIHR has supported a broad portfolio of research into long COVID, including understanding the links between long COVID and PoTS. The £3.35 million LOng COvid Multidisciplinary consortium: Optimising Treatments and servIces acrOss the NHS, or LOCOMOTION, study confirmed that people with long COVID are more likely than others to have orthostatic intolerance, and that these problems are relatively common.

Which 13 NHS Trusts have been selected to pilot the value-based procurement guidance.

The Department is developing Value Based Procurement Standard Guidance to improve the National Health Service’s consistency in the procurement of medical technology in England, shifting the focus from buying the cheapest to considering wider factors to ensure that taxpayer money delivers better outcomes for patients, staff, and the environment.Procurement decisions will be based on a minimum of 60% weighting from five value domains, including the mandated minimum 10% on Social Value. The remaining 40% is a maximum weighting for Whole Life Cost. The guidance includes the choice of 21 questions across the five value domains. For example, where improvement to hospital productivity is assessed, real world evidence on the impact to the length of stay, procedure time, and/or readmission rates will be required.The following 13 NHS trusts, covered by nine procurement teams, are piloting the guidance before national rollout across the NHS in England in early 2026:the Birmingham and Solihull Procurement Collaborative, which itself comprises of the University Hospitals Birmingham NHS Foundation Trust; the Birmingham Women's and Children's NHS Foundation Trust; the Royal Orthopaedic Hospital NHS Foundation Trust; the Birmingham Community Healthcare NHS Foundation Trust; and the Birmingham and Solihull Mental Health Foundation Trust;the Guy's and St Thomas' NHS Foundation Trust;the Mid and South Essex NHS Foundation Trust;the North Bristol NHS Trust;the Oxford University Hospitals NHS Foundation Trust;the Sheffield Teaching Hospitals NHS Foundation Trust;the South Tees Hospitals NHS Foundation Trust;the St George's University Hospitals NHS Foundation Trust; andthe University College London Hospitals NHS Foundation Trust.

What assessment he has made of the potential impact of postural tachycardia syndrome on people’s ability to work.

Postural Tachycardia Syndrome (PoTS) can significantly limit a person's ability to work, though the degree of impact will vary among individuals. For some, symptoms are debilitating and prevent them from working entirely, while others can work with adjustments in place. A person's ability to work will depend on the severity of their symptoms and the demands of the job.The Government is committed to supporting disabled people and people with health conditions, including people with PoTS, with their employment journey. We therefore have a range of specialist initiatives to support individuals to stay in work and get back into work, including those that join up employment and health systems.The 10-Year Health Plan, published in July 2025, set out our intention to break down barriers to opportunity by delivering the holistic support that people need to access and thrive in employment by ensuring a better health service for everyone, regardless of condition or service area. The Plan sets out the vision for what good joined-up care looks like for people with a combination of health and care needs, including for disabled people and those with long-term conditions. Furthermore, it outlines how the neighbourhood health service will join up support from across the work, health and skills systems to help address the multiple complex challenges that often stop people finding and staying in work.

What recent discussions he has had with representatives of he Lobular Moonshot project.

My Rt Hon. Friend, the Secretary of State for Health and Social Care met with representatives of the Lobular Moonshot project on 14 July 2025. Department officials again met with representatives on 29 July 2025, where it was determined that the most pressing research priorities were in discovery science, which sits within the Medical Research Council’s remit. On 18 September researchers involved with the Lobular Moonshot Project met with the Medical Research Council. The Department has also recently exchanged written correspondence with representatives of the Lobular Moonshot project.Both the Medical Research Council and the National Institute for Health and Care Research have committed to continuing to work with the Lobular Moonshot Campaign team to support the development of fundable research proposals in this area and help drive our collective ambition to increase the understanding and effective management of this disease.

What support is available through the NHS for patients with postural tachycardia syndrome requiring (a) ongoing management and (b) rehabilitation.

We are investing in additional capacity to deliver appointments to help bring waiting lists and times down. The Elective Reform Plan, published in January 2025, sets out the specific productivity and reform efforts needed to return to the constitutional standard, that 92% of patients to wait no longer than 18 weeks from referral to treatment by March 2029.Additionally, the shifts outlined in our 10-Year Health Plan will free up hospital-based consultants’ time by shifting care from hospitals to communities, utilising digital technology to reduce administrative burdens, and promoting prevention to reduce the onset and severity of conditions that lead to hospital admissions. This includes expanding community-based services, employing artificial intelligence for productivity, developing integrated neighbourhood health teams, and investing in digital tools and data. These shifts will allow specialists to focus on more complex cases of postural tachycardia syndrome (PoTS), enabling earlier identification and management, and improved patient outcomes.The Department funds health and care research through the National Institute for Health and Care Research (NIHR). The NIHR has supported a broad portfolio of research into long COVID, including understanding the links between long COVID and PoTS. The £3.35 million LOng COvid Multidisciplinary consortium: Optimising Treatments and servIces acrOss the NHS, or LOCOMOTION, study confirmed that people with long COVID are more likely than others to have orthostatic intolerance, and that these problems are relatively common.

What criteria his Department is using to evaluate (a) effectiveness and (b) value in the new NHS medical technology procurement model.

The Department is developing Value Based Procurement Standard Guidance to improve the National Health Service’s consistency in the procurement of medical technology in England, shifting the focus from buying the cheapest to considering wider factors to ensure that taxpayer money delivers better outcomes for patients, staff, and the environment.Procurement decisions will be based on a minimum of 60% weighting from five value domains, including the mandated minimum 10% on Social Value. The remaining 40% is a maximum weighting for Whole Life Cost. The guidance includes the choice of 21 questions across the five value domains. For example, where improvement to hospital productivity is assessed, real world evidence on the impact to the length of stay, procedure time, and/or readmission rates will be required.The following 13 NHS trusts, covered by nine procurement teams, are piloting the guidance before national rollout across the NHS in England in early 2026:the Birmingham and Solihull Procurement Collaborative, which itself comprises of the University Hospitals Birmingham NHS Foundation Trust; the Birmingham Women's and Children's NHS Foundation Trust; the Royal Orthopaedic Hospital NHS Foundation Trust; the Birmingham Community Healthcare NHS Foundation Trust; and the Birmingham and Solihull Mental Health Foundation Trust;the Guy's and St Thomas' NHS Foundation Trust;the Mid and South Essex NHS Foundation Trust;the North Bristol NHS Trust;the Oxford University Hospitals NHS Foundation Trust;the Sheffield Teaching Hospitals NHS Foundation Trust;the South Tees Hospitals NHS Foundation Trust;the St George's University Hospitals NHS Foundation Trust; andthe University College London Hospitals NHS Foundation Trust.

What assessment he has made of the adequacy of the (a) availability and (b) take-up of the covid-19 vaccine for eligible people in the latest period for which data is available.

Vaccine availability is monitored as part of standard operational practice across the UK Health Security Agency (UKHSA), NHS England, and the devolved administrations. The UKHSA collects and analyses data from the vaccination programmes to understand the impact, effectiveness, and any inequalities.The UKHSA has procured COVID-19 vaccines for the upcoming season in line with uptake forecasts received from all four nations of the United Kingdom. Based on procured volumes, it is expected that there is sufficient COVID-19 vaccine available for those eligible to receive a vaccine across the current autumn and winter campaigns. People aged 75 years old and over, those in older adult care homes, and those aged six months old and over who are immunosuppressed are eligible.During the spring 2025 campaign, 60% of those aged 75 years old or over received the COVID-19 vaccine, as did 24.5% of those aged under 75 years old who also have a suppressed immune system. Further information is available at the following link:https://www.gov.uk/government/statistics/national-flu-and-covid-19-surveillance-reports-2025-to-2026-seasonIt is too early in the autumn 2025 campaign to provide coverage data.

What steps his Department is taking to help improve early diagnosis rates for prostate cancer.

We recognise that there is more to be done to ensure that patients have timely access to diagnosis and treatment, and we remain committed to diagnosing all cancer types earlier, including prostate cancer.The Government has invested £16 million towards the Prostate Cancer UK-led TRANSFORM screening trial, which is seeking to find ways to catch prostate cancer in men as early as possible.The Department will publish a National Cancer Plan which will include details on how we will improve outcomes for cancer patients in England, speed up diagnosis and treatment, and ensure patients have access to the latest treatments and technology. Having consulted with key stakeholders and patient groups, the plan will be published early in the new year.Information on the current average waiting time from referral to treatment for prostate cancer in each National Health Service trust is not held centrally. However, we do publish data on the number of people receiving treatment for cancer, broken down by cancer type and including prostate cancer, compared to the 62-day standard. This data is published monthly, and a copy of the latest publication is attached.

What the current average waiting time is from referral to treatment for prostate cancer patients in each NHS trust.

We recognise that there is more to be done to ensure that patients have timely access to diagnosis and treatment, and we remain committed to diagnosing all cancer types earlier, including prostate cancer.The Government has invested £16 million towards the Prostate Cancer UK-led TRANSFORM screening trial, which is seeking to find ways to catch prostate cancer in men as early as possible.The Department will publish a National Cancer Plan which will include details on how we will improve outcomes for cancer patients in England, speed up diagnosis and treatment, and ensure patients have access to the latest treatments and technology. Having consulted with key stakeholders and patient groups, the plan will be published early in the new year.Information on the current average waiting time from referral to treatment for prostate cancer in each National Health Service trust is not held centrally. However, we do publish data on the number of people receiving treatment for cancer, broken down by cancer type and including prostate cancer, compared to the 62-day standard. This data is published monthly, and a copy of the latest publication is attached.

How many children and young people are in receipt of Children and Young People’s Continuing Care packages in the Lancashire and South Cumbria Integrated Care Board area.

Integrated care boards (ICBs) are responsible for the provision and commissioning of services to meet the needs of their local populations. NHS England supports ICBs to implement the National Framework for Children and Young People’s Continuing Care, and it has now started to collect Children and Young People’s Continuing Care activity data as part of the All-age Continuing Care Patient Level Dataset which launched on 1 April 2025, and which is available at the following link:https://digital.nhs.uk/data-and-information/data-collections-and-data-sets/data-sets/all-age-continuing-care-data-set/about-the-all-age-continuing-care-data-setNational data on Children and Young People’s Continuing Care is not yet available. NHS England data shows that the total number of adults aged 18 years old and over in England who are eligible for NHS Continuing Healthcare (CHC) was 50,281 as of the last day of Quarter one of 2025/26. The CHC’s Statistical Press Release for Quarter one of 2025/26 is available at the following link:https://www.england.nhs.uk/statistics/wp-content/uploads/sites/2/2025/08/CHC_Statistical_Press_Release_Q1_2025_26_DQ55g.pdfThe relationship between Children and Young People’s Continuing Care and hospital admissions is not monitored nationally and the data on the numbers of children in receipt of Children and Young People’s Continuing Care packages and the cost of the packages by region is not held centrally. ICBs may hold relevant information as they have a statutory duty to meet the reasonable needs of an individual. For health services, the duty is that of Sections 3 to 6 of the NHS Act 2006 and accompanying regulations.

What the average annual cost is of a Children and Young People’s Continuing Care package by region.

Integrated care boards (ICBs) are responsible for the provision and commissioning of services to meet the needs of their local populations. NHS England supports ICBs to implement the National Framework for Children and Young People’s Continuing Care, and it has now started to collect Children and Young People’s Continuing Care activity data as part of the All-age Continuing Care Patient Level Dataset which launched on 1 April 2025, and which is available at the following link:https://digital.nhs.uk/data-and-information/data-collections-and-data-sets/data-sets/all-age-continuing-care-data-set/about-the-all-age-continuing-care-data-setNational data on Children and Young People’s Continuing Care is not yet available. NHS England data shows that the total number of adults aged 18 years old and over in England who are eligible for NHS Continuing Healthcare (CHC) was 50,281 as of the last day of Quarter one of 2025/26. The CHC’s Statistical Press Release for Quarter one of 2025/26 is available at the following link:https://www.england.nhs.uk/statistics/wp-content/uploads/sites/2/2025/08/CHC_Statistical_Press_Release_Q1_2025_26_DQ55g.pdfThe relationship between Children and Young People’s Continuing Care and hospital admissions is not monitored nationally and the data on the numbers of children in receipt of Children and Young People’s Continuing Care packages and the cost of the packages by region is not held centrally. ICBs may hold relevant information as they have a statutory duty to meet the reasonable needs of an individual. For health services, the duty is that of Sections 3 to 6 of the NHS Act 2006 and accompanying regulations.

What funding his Department has provided to prostate cancer public awareness campaigns in each of the last five years.

We recognise the importance of raising awareness of prostate cancer, to support earlier diagnosis. The Department does not ring-fence funding exclusively for prostate cancer public awareness campaigns. Awareness-raising is often supported via broader cancer or men’s health communication programmes, working in partnership with charities and National Health Service bodies.The NHS, and several other local and national organisations, published information on the signs and symptoms of many different types of cancer, including prostate cancer. This information can be found on the NHS website, at the following link:https://www.nhs.uk/conditions/prostate-cancer/symptoms/In January 2025, NHS England re-launched its Abdominal and urological symptoms of cancer phase of the Help Us Help You public awareness campaigns. These public campaigns aim to increase knowledge of cancer symptoms and address barriers to acting on them, to encourage people to come forward as soon as possible to see their general practitioner.Cancer Alliances receive a place-based funding allocation from the NHS Cancer Programme from which they can draw down to support local awareness and early diagnosis activity. This can be used to raise awareness for a range of cancers, including prostate cancer.

What steps his Department is taking to monitor the impact of Children and Young People’s Continuing Care on hospital admissions among children with complex health needs.

Integrated care boards (ICBs) are responsible for the provision and commissioning of services to meet the needs of their local populations. NHS England supports ICBs to implement the National Framework for Children and Young People’s Continuing Care, and it has now started to collect Children and Young People’s Continuing Care activity data as part of the All-age Continuing Care Patient Level Dataset which launched on 1 April 2025, and which is available at the following link:https://digital.nhs.uk/data-and-information/data-collections-and-data-sets/data-sets/all-age-continuing-care-data-set/about-the-all-age-continuing-care-data-setNational data on Children and Young People’s Continuing Care is not yet available. NHS England data shows that the total number of adults aged 18 years old and over in England who are eligible for NHS Continuing Healthcare (CHC) was 50,281 as of the last day of Quarter one of 2025/26. The CHC’s Statistical Press Release for Quarter one of 2025/26 is available at the following link:https://www.england.nhs.uk/statistics/wp-content/uploads/sites/2/2025/08/CHC_Statistical_Press_Release_Q1_2025_26_DQ55g.pdfThe relationship between Children and Young People’s Continuing Care and hospital admissions is not monitored nationally and the data on the numbers of children in receipt of Children and Young People’s Continuing Care packages and the cost of the packages by region is not held centrally. ICBs may hold relevant information as they have a statutory duty to meet the reasonable needs of an individual. For health services, the duty is that of Sections 3 to 6 of the NHS Act 2006 and accompanying regulations.

If his Department will make an assessment of the potential impact of the introduction of digital ID on levels of registration for the organ donors' register.

NHS Blood and Transplant (NHSBT) is the organ donation organisation for the UK responsible for the NHS Organ Donor Register (ODR), which is available at the following link:https://www.organdonation.nhs.uk/register-your-decision/For the purposes of this response, Digital ID has been assumed to refer to the potential introduction of a citizen ID as recently announced by the UK Government.Presently, NHSBT has made no formal assessment on the potential impact of the introduction of Digital ID on levels of ODR registration. The appropriateness of this will be monitored going forward.

What steps he is taking to increase the availability of histotripsy treatment on the NHS.

Histotripsy is a non-invasive ultrasound treatment that destroys tumours without the need for surgery or radiation. It was one of eight transformative technologies supported through the Government’s Innovative Devices Access Pathway (IDAP) pilot. This programme aimed to streamline patient access to medical devices that address an unmet clinical need in the National Health Service.Through the IDAP, an Unmet Clinical Need Authorisation was granted by the Medicines and Healthcare products Regulatory Agency, exempting the manufacturer from certain regulatory requirements under specific conditions given the critical unmet need of liver cancer, allowing early market access. Histotripsy is now available for conditional use in the NHS for patients with liver tumours. NHS treatments will begin in October 2025 as a first in Europe, strengthening the United Kingdom’s position as a global leader in medical innovation.

What assessment he has made of the availability of continuous positive airway pressure machines for NHS patients diagnosed with sleep apnoea.

No specific assessment has been made by the Department.The provision of treatments for sleep apnoea is a commissioning matter and these decisions are the responsibility of integrated care boards, taking into account the needs of their local populations and national guidance such as the National Institute for Health and Care Excellence (NICE) guidelines on diagnosis and management of obstructive sleep apnoea/hypopnoea syndrome.NICE has recommended continuous positive airway pressure machines (TA139) as a treatment option for adults with moderate or severe symptomatic obstructive sleep apnoea or hypopnoea syndrome, where certain clinical criteria are met.

With reference to his Department's press release entitled 14 NHS trusts the focus of national maternity investigation, published on 15 September, what his planned timeline is for completion of each local trust investigation; what the interim milestones will be; and if he will provide regular updates to Parliament on progress.

The independent investigation is chaired by Baroness Valerie Amos and supported by a small team of expert advisors.Local investigations will be carried out by trained investigators who will spend several days on site at each trust, supported by a small team. Our current expectation is that visits will take place between October and December 2025, though these timings are indicative only, and are subject to final confirmation, particularly in light of the pressures faced by trusts during the winter months.The investigation will produce an initial set of national recommendations by December 2025, with a final report and recommendations to be published in spring 2026. This is due to the ambition, size, and scope of the investigation.The 14 National Health Service trusts were selected by the independent investigation based on a variety of factors, including results from the Care Quality Commission’s Maternity Patient Survey and Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK’s Perinatal Mortality Rates, in addition to variation in case mix, trust type, geographic coverage, provision of care to individuals from diverse backgrounds, and family feedback.Three of the trusts have been included due to their inclusion in previous investigations or reviews, with these three trusts being the Shrewsbury and Telford Hospital NHS Trust, the East Kent Hospitals University NHS Foundation Trust, and the University Hospitals of Morecambe Bay NHS Foundation Trust.By taking this approach, the investigation can capture learning from a wide range of provision and experiences, ensuring the findings are relevant across the system.

With reference to his Department's press release entitled 14 NHS trusts the focus of national maternity investigation, published on 15 September 2025, if he publish the full data and methodology used to select the 14 NHS trusts under investigation.

The independent investigation is chaired by Baroness Valerie Amos and supported by a small team of expert advisors.Local investigations will be carried out by trained investigators who will spend several days on site at each trust, supported by a small team. Our current expectation is that visits will take place between October and December 2025, though these timings are indicative only, and are subject to final confirmation, particularly in light of the pressures faced by trusts during the winter months.The investigation will produce an initial set of national recommendations by December 2025, with a final report and recommendations to be published in spring 2026. This is due to the ambition, size, and scope of the investigation.The 14 National Health Service trusts were selected by the independent investigation based on a variety of factors, including results from the Care Quality Commission’s Maternity Patient Survey and Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK’s Perinatal Mortality Rates, in addition to variation in case mix, trust type, geographic coverage, provision of care to individuals from diverse backgrounds, and family feedback.Three of the trusts have been included due to their inclusion in previous investigations or reviews, with these three trusts being the Shrewsbury and Telford Hospital NHS Trust, the East Kent Hospitals University NHS Foundation Trust, and the University Hospitals of Morecambe Bay NHS Foundation Trust.By taking this approach, the investigation can capture learning from a wide range of provision and experiences, ensuring the findings are relevant across the system.

What steps his Department is taking to help ensure that NHS trusts move into financial surplus by 2030.

The National Health Service priorities and operational planning guidance 2025/26 made it clear that living within budget, reducing waste and increasing productivity is a priority. This year’s financial framework changes include making deficit support funding conditional on performance, implementing a financial override in the Oversight Framework, and introducing additional support for efficiency and productivity through the new Financial Performance and Improvement Programme. The 10-Year Health Plan also made several longer-term commitments to strengthen the NHS financial foundation, which are now being taken forward, including:(a) A commitment to deliver 2% annual productivity growth, which will unlock £17 billion in savings over 3 years.(b) A new approach to NHS financial management including multi-year settlements, and phasing out deficit support funding;(c) Sharper financial incentives including the use of best practice tariffs, and changing the funding model to encourage urgent and emergency care to shift to the community;(d) A fairer geographical distribution of funding, to target areas with disproportionate economic and health challenges; and(e) Reform of the capital regime, giving more power to the frontline and speeding up the capital approvals process.